secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medtronic plc (MDT)
CIK:        0001613103
Form:       8-K
Filed at:   2023-10-23T23:59:59+00:00
Accession:  0001613103-23-000132
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medtronic shareholders approve 2024 ESPP (30M shares); directors re-elected with notable dissent
--------------------------------------------------------------------------------

- 2024 Employee Stock Purchase Plan approved; 30M ordinary shares authorized; first purchase period Jan 1, 2024.
- All 11 director nominees re-elected; O'Leary (107M against) and Powell (102M against) faced largest opposition.
- PwC ratified as FY2024 auditor: 1.06B for, 101.7M against; executive compensation advisory approved: 968M for, 68.9M against.
- Shareholders approved renewal of authority to issue shares, opt out of pre-emption rights, and authorize overseas share repurchases.
- 2014 ESPP to terminate after Dec 31, 2023 purchase period; no new periods under that plan after 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1613103/000161310323000132/0001613103-23-000132-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1613103/000161310323000132/mdt-20231019.htm
  HTML page:      https://secwatch.observer/filing/0001613103-23-000132

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer